These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8251378)
1. Reversibility of thrombin-induced decrease in platelet glycoprotein Ib function. Lu H; Menashi S; Garcia I; Cramer EM; Li H; Tenza D; De Romeuf C; Soria J; Soria C Br J Haematol; 1993 Sep; 85(1):116-23. PubMed ID: 8251378 [TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin. Hourdillé P; Gralnick HR; Heilmann E; Derlon A; Ferrer AM; Vezon G; Nurden AT Blood; 1992 Apr; 79(8):2011-21. PubMed ID: 1562727 [TBL] [Abstract][Full Text] [Related]
3. Reversible translocation of glycoprotein Ib in plasmin-treated platelets: consequences for platelet function. Lu H; Soria C; Soria J; De Romeuf C; Perrot JY; Tenza D; Garcia I; Caen JP; Cramer EM Eur J Clin Invest; 1993 Dec; 23(12):785-93. PubMed ID: 7511534 [TBL] [Abstract][Full Text] [Related]
4. Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib. George JN; Torres MM Blood; 1988 May; 71(5):1253-9. PubMed ID: 3258766 [TBL] [Abstract][Full Text] [Related]
5. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830 [TBL] [Abstract][Full Text] [Related]
6. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. Soslau G; Class R; Morgan DA; Foster C; Lord ST; Marchese P; Ruggeri ZM J Biol Chem; 2001 Jun; 276(24):21173-83. PubMed ID: 11283012 [TBL] [Abstract][Full Text] [Related]
7. Neutralization of the local negative charge carried by glycoprotein (GP)-Ib in ristocetin-induced platelet agglutination. Tanoue K; Jung SM; Yamamoto N; Yamazaki H Thromb Haemost; 1984 Feb; 51(1):79-83. PubMed ID: 6232731 [TBL] [Abstract][Full Text] [Related]
8. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Berndt MC; Du XP; Booth WJ Biochemistry; 1988 Jan; 27(2):633-40. PubMed ID: 2450575 [TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions. Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386 [TBL] [Abstract][Full Text] [Related]
10. Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size. Federici AB; Bader R; Pagani S; Colibretti ML; De Marco L; Mannucci PM Br J Haematol; 1989 Sep; 73(1):93-9. PubMed ID: 2803984 [TBL] [Abstract][Full Text] [Related]
11. Recombinant fragment of von Willebrand factor AR545C inhibits platelet binding to thrombin and platelet adhesion to thrombin-treated endothelial cells. Dardik R; Varon D; Eskaraev R; Tamarin I; Inbal A Br J Haematol; 2000 Jun; 109(3):512-8. PubMed ID: 10886196 [TBL] [Abstract][Full Text] [Related]
12. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers. Gjønnaess E; Solum NO; Brosstad F Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815 [TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains. Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224 [TBL] [Abstract][Full Text] [Related]
14. Effects of leukocyte-derived cathepsin G on platelet membrane glycoprotein Ib-IX and IIb-IIIa complexes: a comparison with thrombin. Molino M; Di Lallo M; Martelli N; de Gaetano G; Cerletti C Blood; 1993 Oct; 82(8):2442-51. PubMed ID: 8400294 [TBL] [Abstract][Full Text] [Related]
15. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Michelson AD; Benoit SE; Kroll MH; Li JM; Rohrer MJ; Kestin AS; Barnard MR Blood; 1994 Jun; 83(12):3562-73. PubMed ID: 8204882 [TBL] [Abstract][Full Text] [Related]
16. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900 [TBL] [Abstract][Full Text] [Related]
17. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox. Chang MC; Lin HK; Peng HC; Huang TF Blood; 1998 Mar; 91(5):1582-9. PubMed ID: 9473223 [TBL] [Abstract][Full Text] [Related]
18. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Berndt MC; Gregory C; Kabral A; Zola H; Fournier D; Castaldi PA Eur J Biochem; 1985 Sep; 151(3):637-49. PubMed ID: 3161731 [TBL] [Abstract][Full Text] [Related]
19. Comparison of thrombin and ristocetin in the interaction between von Willebrand factor and platelets. Harrison RL; McKee PA Blood; 1983 Aug; 62(2):346-53. PubMed ID: 6307433 [TBL] [Abstract][Full Text] [Related]
20. Prelabeled glycoprotein Ib/IX receptors are not cleared from exposed surfaces of thrombin-activated platelets. White JG; Krumwiede MD; Cocking-Johnson D; Escolar G Am J Pathol; 1996 Aug; 149(2):629-38. PubMed ID: 8702001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]